Molecular Description of Familial Defective APOB-100 in Malaysia

被引:6
|
作者
Al-Khateeb, Alyaa R. [1 ,2 ]
Mohd, Mohd Sapawi [3 ]
Yusof, Zukarnai [4 ]
Zilfalil, Bin Alwi [2 ]
机构
[1] Univ Teknol MARA UiTM, Fac Med, Jalan Hosp, Sungai Buloh 47000, Selangor, Malaysia
[2] Univ Sains Malaysia, Sch Med Sci, Ctr Human Genome, Kubang Kerian 16150, Kelantan, Malaysia
[3] Hosp Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia
[4] Univ Sains Malaysia, Sch Med Sci, Dept Med, Kubang Kerian 16150, Kelantan, Malaysia
关键词
APOB-100; gene; Familial defective APOB-100; Mutation; DHPLC; LIPOPROTEIN RECEPTOR GENE; APOLIPOPROTEIN B-100; B GENE; APO-B; MUTATION; HYPERCHOLESTEROLEMIA; IDENTIFICATION;
D O I
10.1007/s10528-013-9609-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial ligand-defective apolipoprotein B-100 is characterized by elevated plasma low-density lipoprotein levels and premature heart disease. This study aims to determine apolipoprotein B gene mutations among Malaysians with clinical diagnoses of familial hypercholesterolemia and to compare the phenotype of patients with apolipoprotein B gene mutations to those with a low-density lipoprotein receptor gene mutation. A group of 164 patients with a clinical diagnosis of familial hypercholesterolemia was analyzed. Amplicons in exon 26 and exon 29 of the apolipoprotein B gene were screened for genetic variants using denaturing gradient high-performance liquid chromatography; 10 variants were identified. Five novel mutations were detected (p.Gln2485Arg, p.Thr3526Ala, p.Glu3666Lys, p.Tyr4343CysfsX221, and p.Arg4297His). Those with familial defective apolipoprotein had a less severe phenotype than those with familial hypercholesterolemia. An apolipoprotein gene defect is present among Malaysian familial hypercholesterolemics. Those with both mutations show a more severe phenotype than those with one gene defect.
引用
收藏
页码:811 / 823
页数:13
相关论文
共 50 条
  • [31] Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque
    Egusa, Genshi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (10) : 1020 - 1022
  • [32] Low density lipoprotein: structure, dynamics, and interactions of apoB-100 with lipids
    Murtola, Teemu
    Vuorela, Timo A.
    Hyvonen, Marja T.
    Marrink, Siewert-Jan
    Karttunen, Mikko
    Vattulainen, Ilpo
    SOFT MATTER, 2011, 7 (18) : 8135 - 8141
  • [33] Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation
    Brunelli, R
    Mei, G
    Krasnowska, EK
    Pierucci, F
    Zichella, L
    Ursini, F
    Parasassi, T
    BIOCHEMISTRY, 2000, 39 (45) : 13897 - 13903
  • [34] Microsomal triglyceride transfer protein is essential for hepatic secretion of apoB-100 and apoB-48 but not triglyceride
    Hui, TY
    Olivier, LM
    Kang, S
    Davis, RA
    JOURNAL OF LIPID RESEARCH, 2002, 43 (05) : 785 - 793
  • [35] Nasal immunization with an apoB-100 peptide-cholera toxin subunit B fusion protein attenuates atherosclerosis and induces protective T cell immunity specific for apoB-100
    Klingenberg, R.
    Lebens, M.
    Fredrikson, G. N.
    Strodthoff, D.
    Rudling, M.
    Ketelhuth, D.
    Gerdes, N.
    Holmgren, J.
    Nilsson, J.
    Hansson, G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 241 - 241
  • [36] Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro
    Yang, CY
    Gu, ZW
    Yang, ML
    Lin, SN
    Garcia-Prats, AJ
    Rogers, LK
    Welty, SE
    Smith, CV
    JOURNAL OF LIPID RESEARCH, 1999, 40 (04) : 686 - 698
  • [37] Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100
    Tse, Kevin
    Gonen, Ayelet
    Sidney, John
    Ouyang, Hui
    Witztum, Joseph L.
    Sette, Alessandro
    Tse, Harley
    Ley, Klaus
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [38] Apob-100 Peptide Complexed To Nanoparticles as Therapeutic Modality in ASCVD: A Translational Study
    Chyu, Kuang-yuh
    Zhao, Xiaoning
    Zhou, Jianchang
    Dimayuga, Paul C.
    Lio, Wai Man
    Cercek, Bojan
    Trac, Noah
    Chung, Eun Ji
    Shah, Prediman K.
    CIRCULATION RESEARCH, 2021, 129 (12) : E237 - E238
  • [39] Estimation of the age of the ancestral arginine(3500)->glutamine mutation in human ApoB-100
    Myant, NB
    Forbes, SA
    Day, INM
    Gallagher, J
    GENOMICS, 1997, 45 (01) : 78 - 87
  • [40] Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCl in vitro
    Yang, CY
    Gu, ZW
    Yang, HX
    Yang, M
    Gotto, AM
    Smith, CV
    FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (01) : 82 - 89